Clinical Trial Update: Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing prasugrel versus ticagrelor and two duration strategies (12 months versus 1-3 months) after acute myocardial infarction treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Conditions: Myocardial Infarction (MI) | Phase 4 | Status: NOT_YET_RECRUITING